Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 14, 2013 - Issue 14
Submit an article Journal homepage
465
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluations

Omacetaxine mepesuccinate (synribo) – newly launched in chronic myeloid leukemia

Aziz NazhaThe University of Texas, M.D. Anderson Cancer Center, Department of Leukemia Unit, 428, 1515 Holcombe Blvd, Houston, TX 77030, USA+1 713 745 4009; [email protected]
,
Hagop KantarjianThe University of Texas, M.D. Anderson Cancer Center, Department of Leukemia Unit, 428, 1515 Holcombe Blvd, Houston, TX 77030, USA+1 713 745 4009; [email protected]
,
Jorge CortesThe University of Texas, M.D. Anderson Cancer Center, Department of Leukemia Unit, 428, 1515 Holcombe Blvd, Houston, TX 77030, USA+1 713 745 4009; [email protected]
&
Alfonso Quintás-CardamaThe University of Texas, M.D. Anderson Cancer Center, Department of Leukemia Unit, 428, 1515 Holcombe Blvd, Houston, TX 77030, USA+1 713 745 4009; [email protected]
, MD
Pages 1977-1986 | Published online: 23 Jul 2013

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Patricia Kropf, Gisoo Barnes, Boxiong Tang, Ashutosh Pathak & Jean-Pierre J. Issa. (2016) Healthcare utilization and costs associated with tyrosine kinase inhibitor switching in patients with chronic myeloid leukemia. Leukemia & Lymphoma 57:4, pages 935-941.
Read now

Articles from other publishers (12)

Chiao-Hui Hsieh, Chen-Tsung Huang, Yi-Sheng Cheng, Chun-Hua Hsu, Wen-Ming Hsu, Yun-Hsien Chung, Yen-Lin Liu, Tsai-Shan Yang, Chia-Yu Chien, Yu-Hsuan Lee, Hsuan-Cheng Huang & Hsueh-Fen Juan. (2023) Homoharringtonine as a PHGDH inhibitor: Unraveling metabolic dependencies and developing a potent therapeutic strategy for high-risk neuroblastoma. Biomedicine & Pharmacotherapy 166, pages 115429.
Crossref
Sudip Kumar Mandal, Agnidipta Das, Anindya Bose, Vagish Dwibedi, Paramita Ganguly, Sipra Sarkar, Ranjana Prakash, Biplab Kumar Dey, Sanjeet Mandal & Santosh Kumar Rath. (2023) Hetero Cyclic Compounds in the Treatment of Triple-Negative Breast Cancer. Current Cancer Therapy Reviews 19:3, pages 237-259.
Crossref
Elena Porcù, Francesca Maule, Lorenzo Manfreda, Elena Mariotto, Silvia Bresolin, Alice Cani, Roberta Bortolozzi, Alessandro Della Puppa, Diana Corallo, Giampietro Viola, Elena Rampazzo & Luca Persano. (2023) Identification of Homoharringtonine as a potent inhibitor of glioblastoma cell proliferation and migration. Translational Research 251, pages 41-53.
Crossref
Jinying Gu, Qiuyu Wu, Qiuyue Zhang, Qidong You & Lei Wang. (2022) A decade of approved first-in-class small molecule orphan drugs: Achievements, challenges and perspectives. European Journal of Medicinal Chemistry 243, pages 114742.
Crossref
Gazmend Temaj, Silvia Chichiarelli, Margherita Eufemi, Fabio Altieri, Rifat Hadziselimovic, Ammad Ahmad Farooqi, Ilhan Yaylim & Luciano Saso. (2022) Ribosome-Directed Therapies in Cancer. Biomedicines 10:9, pages 2088.
Crossref
Akihiro Ochi, Makoto Yoritate, Tomofumi Miyamoto, Kazuteru Usui, Gorawit Yusakul, Waraporn Putalun, Hiroyuki Tanaka, Go Hirai, Satoshi Morimoto & Seiichi Sakamoto. (2022) Harringtonine Ester Derivatives with Enhanced Antiproliferative Activities against HL-60 and HeLa Cells. Journal of Natural Products 85:2, pages 345-351.
Crossref
Yunxiang Zhang, Xiaoyang Li, Xiangqin Weng, Yang Shen, Yu Chen, Yu Zheng, Huijin Zhao, Jianhua You, Yuanfei Mao, Lining Wang, Min Wu, Yan Sheng, Jing Wu, Jiong Hu, Qiusheng Chen & Junmin Li. (2021) Optimization of idarubicin and cytarabine induction regimen with homoharringtonine for newly diagnosed acute myeloid leukemia patients based on the peripheral blast clearance rate: A single‐arm, phase 2 trial ( RJ‐AML 2014) . American Journal of Hematology 97:1, pages 43-51.
Crossref
Bahare Salehi, Paolo Zucca, Mehdi Sharifi-Rad, Raffaele Pezzani, Sadegh Rajabi, William N. Setzer, Elena Maria Varoni, Marcello Iriti, Farzad Kobarfard & Javad Sharifi-Rad. (2018) Phytotherapeutics in cancer invasion and metastasis. Phytotherapy Research 32:8, pages 1425-1449.
Crossref
Y. Chang, F.-C. Meng, R. Wang, C.M. Wang, X.-Y. Lu & Q.-W. Zhang. 2017. 339 373 .
Diana Cláudia Gouveia Alves Pinto, Ana Maria Loureiro Seca & Artur Manuel Soares Silva. 2017. Anticancer Plants: Clinical Trials and Nanotechnology. Anticancer Plants: Clinical Trials and Nanotechnology 105 151 .
Wei-Lun Chen, Li Pan, A. Douglas Kinghorn, Steven M. Swanson & Joanna E. Burdette. (2016) Silvestrol induces early autophagy and apoptosis in human melanoma cells. BMC Cancer 16:1.
Crossref
Gayong Shim, Sangbin Lee, Junhyeok Choi, Soondong Lee, Chan-Wha Kim & Yu-Kyoung Oh. (2014) Liposomal Co-Delivery of Omacetaxine Mepesuccinate and Doxorubicin for Synergistic Potentiation of Antitumor Activity. Pharmaceutical Research 31:8, pages 2178-2185.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.